Seroprevalence of Poliovirus Types 1, 2, and 3 Among Children Aged 6–11 Months: Variations Across Survey Rounds in High-Risk Areas of Pakistan
Authors:
- Imtiaz HussainImtiaz Hussain
- Ahmad KhanAhmad Khan
- Muhammad UmerMUMuhammad Umer
- Muhammad SajidMSMuhammad Sajid
- Haider AbbasHaider Abbas
- Muhammad Masroor AlamMAMuhammad Masroor Alam
- Altaf BosanABAltaf Bosan
- Jeffrey PartridgeJPJeffrey Partridge
- Rehan HafizRHRehan Hafiz
- Anwar-Ul HaqAHAnwar-Ul Haq
- Sajid SoofiSajid Soofi
Open Access
Abstract
Background: The current polio epidemiology in Pakistan poses a unique challenge for global eradication, with polio transmission dynamics influenced by regional variations in immunity and disparities in immunization coverage. This study assesses the immunity level for all three poliovirus types among children aged 6–11 months in polio high-risk regions of Pakistan. Methods: Four consecutive rounds of cross-sectional serological surveys were conducted in polio high-risk areas of Pakistan between November 2016 and October 2023. Twelve high-risk areas were covered in the first three rounds of the survey, while 44 high-risk areas were covered in the fourth round. 25 clusters from each geographical stratum were selected utilizing probability proportional to size. Results: Across the four rounds of the survey, 32,907 children aged 6–11 months from 2084 clusters and 32,371 households were covered. Comparative analysis across the survey rounds showed that seroprevalence of poliovirus type 1 was high in provinces (>95%), albeit consistently lower in Balochistan (going down to 89.7% in Round 4). Type 2 seroprevalence was significantly lower and more heterogeneous, from 34.6% in Sindh to 83.4% in Punjab, with sharp declines by round 4, particularly in Balochistan (40.4%). Type 3 seroprevalence was overall high (>94% in Punjab, Sindh, and KPK) but dropped in the last round, while Balochistan exhibited continually lower immunity (81.1%). Conclusions: The findings reflect the variations in population immunity to poliovirus in the country, with notable fluctuations over the years. The gaps in type 2 immunity over time and consistently lowest in Balochistan highlight the need for continued monitoring of immunity levels and adaptable vaccination strategies.Keywords
All Related Versions
Funding Information
- Bill and Melinda Gates Foundation (OPP1156736)
This publication has 46 references indexed in Scilit:
- The negative impact of the COVID-19 Pandemic on immunization and the positive impact on Polio eradication in Pakistan and AfghanistanJournal of Infection, 2022
- Polio amidst COVID‐19 in Pakistan: Ongoing efforts, challenges, and recommendationsThe International Journal of Health Planning and Management, 2022
- Delays in polio vaccination programs due to COVID-19 in Pakistan: a major threat to Pakistan's long war against polio virusPublic Health, 2020
- Immunity and field efficacy of type 2-containing polio vaccines after cessation of trivalent oral polio vaccine: A population-based serological study in PakistanVaccine: X, 2020
- COVID‐19 in Pakistan: Impact on global polio eradication initiativeJournal of Medical Virology, 2020
- Standardized Methods for Detection of Poliovirus Antibodies2016
- Poliovirus vaccination options for achieving eradication and securing the endgameCurrent Opinion in Virology, 2013
- Polio vaccines and the eradication of poliomyelitisThe Lancet, 2012
- The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001–11: a retrospective analysisThe Lancet, 2012
- Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trialThe Lancet, 2010